# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-24-012732
Filing Date
2024-03-22
Accepted
2024-03-22 16:06:44
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-03-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | a002023_annualreportx0320x.pdf | ARS | 23611792
| Complete submission text file | 0001628280-24-012732.txt |  | 32417537

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33637 | Film No.: 24775237
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)